Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation

Patricia G. Yancey, John Blakemore, Lei Ding, Daping Fan, Cheryl D. Overton, Youmin Zhang, MacRae F. Linton, Sergio Fazio

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Objective: The balance between apoptosis susceptibility and efferocytosis of macrophages is central to plaque remodeling and inflammation. LRP-1 and its ligand, apolipoprotein E, have been implicated in efferocytosis and apoptosis in some cell types. We investigated the involvement of the macrophage LRP-1/apolipoprotein E axis in controlling plaque apoptosis and efferocytosis. Method and results: LRP-1-/- macrophages displayed nearly 2-fold more TUNEL positivity compared to wild-type cells in the presence of DMEM alone or with either lipopolysaccharide or oxidized low-density lipoprotein. The survival kinase, phosphorylated Akt, was barely detectable in LRP-1-/- cells, causing decreased phosphorylated Bad and increased cleaved caspase-3. Regardless of the apoptotic stimulation and degree of cell death, LRP-1 macrophages displayed enhanced inflammation with increased IL-1β, IL-6, and tumor necrosis factor-α expression. Efferocytosis of apoptotic macrophages was reduced by 60% in LRP-1 vs wild-type macrophages despite increased apolipoprotein E expression by both LRP-1-/- phagocytes and wild-type apoptotic cells. Compared to wild-type macrophage lesions, LRP-1 -/- lesions had 5.7-fold more necrotic core with more dead cells not associated with macrophages. Conclusion: Macrophage LRP-1-/- deficiency increases cell death and inflammation by impairing phosphorylated Akt activation and efferocytosis. Increased apolipoprotein E expression in LRP-1-/- macrophages suggests that the LRP-1/apolipoprotein E axis regulates the balance between apoptosis and efferocytosis, thereby preventing necrotic core formation.

Original languageEnglish (US)
Pages (from-to)787-795
Number of pages9
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume30
Issue number4
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

Macrophages
Apolipoproteins E
Apoptosis
Inflammation
Cell Death
In Situ Nick-End Labeling
Phagocytes
Interleukin-1
Caspase 3
Lipopolysaccharides
Interleukin-6
Phosphotransferases
Tumor Necrosis Factor-alpha
Ligands

Keywords

  • Apolipoprotein E
  • Apoptosis
  • Efferocytosis
  • Inflammation
  • LRP-1
  • Necrosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. / Yancey, Patricia G.; Blakemore, John; Ding, Lei; Fan, Daping; Overton, Cheryl D.; Zhang, Youmin; Linton, MacRae F.; Fazio, Sergio.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 30, No. 4, 04.2010, p. 787-795.

Research output: Contribution to journalArticle

Yancey, Patricia G. ; Blakemore, John ; Ding, Lei ; Fan, Daping ; Overton, Cheryl D. ; Zhang, Youmin ; Linton, MacRae F. ; Fazio, Sergio. / Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2010 ; Vol. 30, No. 4. pp. 787-795.
@article{2e009e9099554c08a1d81944e86851db,
title = "Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation",
abstract = "Objective: The balance between apoptosis susceptibility and efferocytosis of macrophages is central to plaque remodeling and inflammation. LRP-1 and its ligand, apolipoprotein E, have been implicated in efferocytosis and apoptosis in some cell types. We investigated the involvement of the macrophage LRP-1/apolipoprotein E axis in controlling plaque apoptosis and efferocytosis. Method and results: LRP-1-/- macrophages displayed nearly 2-fold more TUNEL positivity compared to wild-type cells in the presence of DMEM alone or with either lipopolysaccharide or oxidized low-density lipoprotein. The survival kinase, phosphorylated Akt, was barely detectable in LRP-1-/- cells, causing decreased phosphorylated Bad and increased cleaved caspase-3. Regardless of the apoptotic stimulation and degree of cell death, LRP-1 macrophages displayed enhanced inflammation with increased IL-1β, IL-6, and tumor necrosis factor-α expression. Efferocytosis of apoptotic macrophages was reduced by 60{\%} in LRP-1 vs wild-type macrophages despite increased apolipoprotein E expression by both LRP-1-/- phagocytes and wild-type apoptotic cells. Compared to wild-type macrophage lesions, LRP-1 -/- lesions had 5.7-fold more necrotic core with more dead cells not associated with macrophages. Conclusion: Macrophage LRP-1-/- deficiency increases cell death and inflammation by impairing phosphorylated Akt activation and efferocytosis. Increased apolipoprotein E expression in LRP-1-/- macrophages suggests that the LRP-1/apolipoprotein E axis regulates the balance between apoptosis and efferocytosis, thereby preventing necrotic core formation.",
keywords = "Apolipoprotein E, Apoptosis, Efferocytosis, Inflammation, LRP-1, Necrosis",
author = "Yancey, {Patricia G.} and John Blakemore and Lei Ding and Daping Fan and Overton, {Cheryl D.} and Youmin Zhang and Linton, {MacRae F.} and Sergio Fazio",
year = "2010",
month = "4",
doi = "10.1161/ATVBAHA.109.202051",
language = "English (US)",
volume = "30",
pages = "787--795",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation

AU - Yancey, Patricia G.

AU - Blakemore, John

AU - Ding, Lei

AU - Fan, Daping

AU - Overton, Cheryl D.

AU - Zhang, Youmin

AU - Linton, MacRae F.

AU - Fazio, Sergio

PY - 2010/4

Y1 - 2010/4

N2 - Objective: The balance between apoptosis susceptibility and efferocytosis of macrophages is central to plaque remodeling and inflammation. LRP-1 and its ligand, apolipoprotein E, have been implicated in efferocytosis and apoptosis in some cell types. We investigated the involvement of the macrophage LRP-1/apolipoprotein E axis in controlling plaque apoptosis and efferocytosis. Method and results: LRP-1-/- macrophages displayed nearly 2-fold more TUNEL positivity compared to wild-type cells in the presence of DMEM alone or with either lipopolysaccharide or oxidized low-density lipoprotein. The survival kinase, phosphorylated Akt, was barely detectable in LRP-1-/- cells, causing decreased phosphorylated Bad and increased cleaved caspase-3. Regardless of the apoptotic stimulation and degree of cell death, LRP-1 macrophages displayed enhanced inflammation with increased IL-1β, IL-6, and tumor necrosis factor-α expression. Efferocytosis of apoptotic macrophages was reduced by 60% in LRP-1 vs wild-type macrophages despite increased apolipoprotein E expression by both LRP-1-/- phagocytes and wild-type apoptotic cells. Compared to wild-type macrophage lesions, LRP-1 -/- lesions had 5.7-fold more necrotic core with more dead cells not associated with macrophages. Conclusion: Macrophage LRP-1-/- deficiency increases cell death and inflammation by impairing phosphorylated Akt activation and efferocytosis. Increased apolipoprotein E expression in LRP-1-/- macrophages suggests that the LRP-1/apolipoprotein E axis regulates the balance between apoptosis and efferocytosis, thereby preventing necrotic core formation.

AB - Objective: The balance between apoptosis susceptibility and efferocytosis of macrophages is central to plaque remodeling and inflammation. LRP-1 and its ligand, apolipoprotein E, have been implicated in efferocytosis and apoptosis in some cell types. We investigated the involvement of the macrophage LRP-1/apolipoprotein E axis in controlling plaque apoptosis and efferocytosis. Method and results: LRP-1-/- macrophages displayed nearly 2-fold more TUNEL positivity compared to wild-type cells in the presence of DMEM alone or with either lipopolysaccharide or oxidized low-density lipoprotein. The survival kinase, phosphorylated Akt, was barely detectable in LRP-1-/- cells, causing decreased phosphorylated Bad and increased cleaved caspase-3. Regardless of the apoptotic stimulation and degree of cell death, LRP-1 macrophages displayed enhanced inflammation with increased IL-1β, IL-6, and tumor necrosis factor-α expression. Efferocytosis of apoptotic macrophages was reduced by 60% in LRP-1 vs wild-type macrophages despite increased apolipoprotein E expression by both LRP-1-/- phagocytes and wild-type apoptotic cells. Compared to wild-type macrophage lesions, LRP-1 -/- lesions had 5.7-fold more necrotic core with more dead cells not associated with macrophages. Conclusion: Macrophage LRP-1-/- deficiency increases cell death and inflammation by impairing phosphorylated Akt activation and efferocytosis. Increased apolipoprotein E expression in LRP-1-/- macrophages suggests that the LRP-1/apolipoprotein E axis regulates the balance between apoptosis and efferocytosis, thereby preventing necrotic core formation.

KW - Apolipoprotein E

KW - Apoptosis

KW - Efferocytosis

KW - Inflammation

KW - LRP-1

KW - Necrosis

UR - http://www.scopus.com/inward/record.url?scp=77950888338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950888338&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.109.202051

DO - 10.1161/ATVBAHA.109.202051

M3 - Article

C2 - 20150557

AN - SCOPUS:77950888338

VL - 30

SP - 787

EP - 795

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 4

ER -